leisure time
Previous article:
Jerome Adams on the need for new antivirals for Covid
Next article: Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview
Next article: Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview
leisure time
explore
-
Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs
2025-09-06 01:43 -
Shionogi licenses Pompe disease therapy from Maze Therapeutics
2025-09-06 01:19 -
NIH director takes cautious approach to Biden drug pricing priority
2025-09-06 01:14 -
eGenesis tests gene
2025-09-06 00:59 -
Why doctors need education on FDA device approval process
2025-09-06 00:19 -
The surgeon had a dilemma only a Nazi medical text could resolve
2025-09-05 23:16